Skip to main content

Advertisement

SpringerLink
Log in

Hepatitis C in the setting of kidney, heart, lung, and bone marrow transplants

  • Published:
Current Hepatitis Reports Aims and scope Submit manuscript

Abstract

Hepatitis C virus (HCV) infection is a worldwide epidemic that is causing substantial morbidity and mortality in the general population. Due to inherent risks of HCV transmission through blood and tissue, solid organ and bone marrow transplant recipients have a higher incidence of HCV infection than that of the general population, especially in those transplanted prior to widespread screening for HCV in the early 1990s. The impact of HCV infection in liver transplantation is well characterized, but is less frequently discussed in kidney, heart, lung, and bone marrow transplantation. This article provides a comprehensive and current review of the literature with regard to the epidemiology, pathogenesis, outcome, and treatment of HCV infection in the setting of kidney, heart, lung, and bone marrow transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Yen T, Keefe EB, Ahmed A: The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 2003, 36:47–53.

    Article  PubMed  Google Scholar 

  2. Gane E, Pilmore H: Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002, 74:427–437.

    Article  PubMed  CAS  Google Scholar 

  3. Pereira BJG, Wright TL, Schmid CH, et al.: Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study. Kidney Int 1994, 46:886–892.

    Article  PubMed  CAS  Google Scholar 

  4. Batty DS Jr, Swanson SJ, Kirk AD, et al.: Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 2001, 1:179–184.

    PubMed  Google Scholar 

  5. Fabrizio F, Martin P, Ponticelli C: Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001, 38:919–934.

    Google Scholar 

  6. Fagiuoli S, Minniti F, Pevere S, et al.: HBV and HCV infections in heart transplant recipients. J Heart Lung Transplant 2001, 20:718–724.

    Article  PubMed  CAS  Google Scholar 

  7. Lunel F, Cadranel J, Rosenheim M, et al.: Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics and impact on survival. Gastroenterology 2000, 119:1064–1074.

    PubMed  CAS  Google Scholar 

  8. Rodriquez-Inigo E, Tomas J, Gomez-Garcia de Soria V, et al.: Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: results from a prospective study. Blood 1997, 90:1326–1331.

    Google Scholar 

  9. Kolho E, Ruutu P, Ruutu T: Hepatitis C infection in BMT patients. Bone Marrow Transplant 1993, 11:119–123.

    PubMed  CAS  Google Scholar 

  10. Fujii Y, Kaku K, Tanaka M: Hepatitis C infection and liver disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994, 13:523–526.

    PubMed  CAS  Google Scholar 

  11. Kallinowski B, Hergesell O, Zeier M: Clinical impact of hepatitis C virus infection in the renal transplant recipient. Nephron 2002, 91:541–546.

    Article  PubMed  Google Scholar 

  12. Shuhart MC, Myerson D, Childs BH, et al.: Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. Blood 1994, 84:3229–3235.

    PubMed  CAS  Google Scholar 

  13. Lauer GM, Walker BD: Medical progress: hepatitis C virus infection. N Engl J Med 2001, 345:41–52. An excellent review article on the current status of our knowledge regarding HCV.

    Article  PubMed  CAS  Google Scholar 

  14. Liang TJ, Rehermann B, Seeff L, et al.: Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med 2000, 132:296–305.

    PubMed  CAS  Google Scholar 

  15. Morales JM, Campistol JM, Dominguez-Gil B: Hepatitis C virus infection and kidney transplantation. Semin Nephrol 2002, 22:365–374.

    PubMed  Google Scholar 

  16. Locasciulli A, Testa M, Pontisso P, et al.: Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1997, 19:237–240.

    Article  PubMed  CAS  Google Scholar 

  17. Maruta A, Kanamori H, Fukawa H, et al.: Liver function tests of recipients with hepatitis C virus infection after bone marrow transplantation. Bone Marrow Transplant 1994, 13:417–422.

    PubMed  CAS  Google Scholar 

  18. Zylberberg H, Nalpas B, Carnot F, et al.: Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant 2002, 17:129–133.

    Article  PubMed  Google Scholar 

  19. Rao KV, Anderson R, Kasiske BL, Dahl DC: Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993, 94:241–250.

    Article  PubMed  CAS  Google Scholar 

  20. Angelucci E, Muretto P, Nicolucci A, et al.: Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002, 100:17–21.

    Article  PubMed  CAS  Google Scholar 

  21. Ong JP, Barnes DS, Younossi ZM, et al.: Outcome of de novo hepatitis C virus infection in heart transplant recipients. Hepatology 1999, 30:1293–1298.

    Article  PubMed  CAS  Google Scholar 

  22. Delladetsima JK, Boletis JN, Makris F, et al.: Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Liver Transpl Surg 1999, 5:294–300.

    Article  PubMed  CAS  Google Scholar 

  23. Toth CM, Pascual M, Chung RT, et al.: Hepatitis C virusassociated fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1998, 66:1254–1257.

    Article  PubMed  CAS  Google Scholar 

  24. Strasser SI, Myerson D, Spurgeon CL, et al.: Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10 year follow-up. Hepatology 1999, 29:1893–1899.

    Article  PubMed  CAS  Google Scholar 

  25. Locasciulli A, Testa M, Valsecchi MG, et al.: The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the infectious disease working party of the European blood and marrow transplantation group. Transplantation 1999, 68:1486–1491.

    Article  PubMed  CAS  Google Scholar 

  26. Locasciulli A, Bacigalupo A, VanLint MT, et al.: Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 1991, 52:315–318.

    Article  PubMed  CAS  Google Scholar 

  27. Akiyama H, Yoshinaga H, Tanaka T, et al.: Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients. Bone Marrow Transplant 1997, 20:993–995.

    Article  PubMed  CAS  Google Scholar 

  28. Ljungman P, Johansson N, Aschan J, et al.: Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995, 86:1614–1618.

    PubMed  CAS  Google Scholar 

  29. Yildiz A, Tutuncu Y, Yazici H, et al.: Association between hepatitis C virus infection and development of posttransplant diabetes mellitus in renal transplant recipients. Transplantation 2002, 74:1109–1113.

    Article  PubMed  Google Scholar 

  30. Corell A, Morales JM, Mandrono A, et al.: Immunosuppression induced by hepatitis C virus infection reduces acute renaltransplant rejection. Lancet 1995, 346:1497–1498.

    Article  PubMed  CAS  Google Scholar 

  31. Marelli D, Bresson J, Laks H, et al.: Hepatitis C positive donors in heart transplantation. Am J Transplant 2002, 2:443–447.

    Article  PubMed  Google Scholar 

  32. Dal Bello B, Klersy C, Grossi P, et al.: Combined human cytomegalovirus and hepatitis C virus infections increase the risk of allograft vascular disease in heart transplant recipients. Transplant Proc 1998, 30:2086–2090.

    Article  Google Scholar 

  33. Buda A, Caforio A, Calabrese F, et al.: Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr (EBV) infection. Transpl Int 2000, 13(suppl 1):S402-S405.

    Article  PubMed  Google Scholar 

  34. Stempel CA, Lake J, Kuo G, et al.: Hepatitis C: its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993, 55:273–276.

    Article  PubMed  CAS  Google Scholar 

  35. Ynares C, Johnson HK, Kerlin T, et al.: Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival: a 5- and 10-year follow-up. Transplant Proc 1993, 25:1466–1468.

    PubMed  CAS  Google Scholar 

  36. Meier-Kriesche H, Ojo AO, Hanson JA, et al.: Hepatitis C antibody status and outcomes in renal transplant recipients. Transplantation 2001, 72:241–244. An analysis of the impact of HCV on renal transplant outcomes using a very large database.

    Article  PubMed  CAS  Google Scholar 

  37. Pereira BJG, Natov SN, Bouthot BA, et al.: Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998, 53:1374–1381.

    Article  PubMed  CAS  Google Scholar 

  38. Mathurin P, Mouquet C, Poynard T, et al.: Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999, 29:257–263.

    Article  PubMed  CAS  Google Scholar 

  39. Hanafusa T, Ichikawa Y, Kishikawa H, et al.: Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998, 66:471–476.

    Article  PubMed  CAS  Google Scholar 

  40. Bouthot BA, Murthy BVR, Schmid CH, et al.: Long-term followup of hepatitis C virus infection among organ transplant recipients. Transplantation 1997, 63:849–853.

    Article  PubMed  CAS  Google Scholar 

  41. Breitenfeldt MK, Rasenack J, Berthold H, et al.: Impact of hepatitis B and C on graft loss and mortality on patients after kidney transplantation. Clin Transplant 2002, 16:130–136.

    Article  PubMed  Google Scholar 

  42. Natov NN, Lau JYN, Ruthazer R, et al.: Hepatitis C virus genotype does not effect patient survival among renal transplant candidates. Kidney Int 1999, 56:700–706.

    Article  PubMed  CAS  Google Scholar 

  43. Morales JM, Campistol JM, Castellano G, et al.: Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995, 47:236–240.

    Article  PubMed  CAS  Google Scholar 

  44. Rostaing L, Modesto A, Baron E, et al.: Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron 1996, 74:512–516.

    Article  PubMed  CAS  Google Scholar 

  45. Magnone M, Holley J, Shapiro R, et al.: Interferon-alphainduced acute renal allograft rejection. Transplantation 1995, 59:1068–1070.

    Article  PubMed  CAS  Google Scholar 

  46. Garnier JL, Chevallier P, Dubernard JM, et al.: Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients. Transplant Proc 1997, 29:783.

    Article  PubMed  CAS  Google Scholar 

  47. Huraib S, Iqbal A, Tanimu D, Abdullah A: Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C. Am J Nephrol 2001, 21:435–440.

    Article  PubMed  CAS  Google Scholar 

  48. Giardini C, Galimberti M, Lucarelli G, et al.: Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia. Bone Marrow Transplant 1997, 20:767–772.

    Article  PubMed  CAS  Google Scholar 

  49. Ljungman P, Andersson J, Aschan J, et al.: Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation. Clin Infect Dis 1996, 23:167–169.

    PubMed  CAS  Google Scholar 

  50. Fagiuoli S, Cooper DKC, Zuhdi N: Hepatitis C status of heart transplant recipients. Clin Transplant 1998, 12:5–10.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Division, Liver Transplantation Program, Mayo Mail Stop 36, A 543, 420 Delaware Street SE, 55455, Minneapolis, MN, USA

    Scott Keeley MD & John R. Lake MD

Authors
  1. Scott Keeley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John R. Lake MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keeley, S., Lake, J.R. Hepatitis C in the setting of kidney, heart, lung, and bone marrow transplants. Curr hepatitis rep 2, 159–165 (2003). https://doi.org/10.1007/s11901-003-0018-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11901-003-0018-x

Keywords

Search

Navigation